Newsroom
Company news, product launches and press coverage from EClinCloud.
Good News! EClinCloud Named to the 2025 China Healthcare Digitalization Top 20Recently, at the "WIM2025 Innovators Annual Conference," a thousand-attendee conference hosted by EqualOcean and focused on AI-driven industrial transformation, the closely watched annual list, "2025 China Healthcare Digitalization Top 20," was officially released. EClinCloud was selected for its AI innovation achievements, marking renewed authoritative recognition of the company's leading AI capabilities in clinical research. The list highlights companies' digital enablement value in healthcare settings.
EClinCloud Attends the 2025 Ningbo Biopharmaceutical Industry Development ConferenceOn December 5–6, the 4th China–Ningbo Biopharmaceutical Industry Development Conference, themed "Surging East China Sea, Pharma Shaping the Future: Ningbo Biopharmaceuticals Advancing Toward the 15th Five-Year Plan," was held in Ningbo Qianwan New Area. Organized by Hangzhou Bay Life Science Park (BioVillage), the conference was chaired by Zhao Yufen, Member of the Chinese Academy of Sciences and Dean of the Institute of New Drug Technology at Ningbo University, who delivered the opening remarks. The event featured 8 major tracks and attracted nearly 1,000 attendees.
EClinCloud Invites You to the 2025 Ningbo Biopharmaceutical Industry Development ConferenceOn December 5–6, the 4th China–Ningbo Biopharmaceutical Industry Development Conference will be held in Ningbo Qianwan New Area. The conference will focus on the core themes of R&D innovation and international cooperation, highlighting breakthrough pathways in frontier fields such as AI in pharmaceuticals and in vivo CAR-T, and providing an in-depth analysis of new investment and financing dynamics for innovative drugs as well as medical device innovation and practice.
Thanksgiving Special | EClinCloud's Reputation, Written Together by Our UsersThis Thanksgiving, we would like to share genuine feedback from our clients. It is this recognition and trust that enables EClinCloud to continue progressing. Thank you to all the partners who believe in EClinCloud—your voices strengthen our resolve as we move forward.
Join EClinCloud at the 2025 Qisi Conference to Discuss New Practices in AI + Clinical ResearchFrom November 24 to 26, 2025, the 17th China Pharmaceutical Entrepreneurs, Scientists, and Investors Conference (abbreviated as the "2025 Qisi Conference") will be held at the Zhongguancun Exhibition Center Conference Center in Beijing. Anchored around "Structural Inflection Point," the conference brings together key stakeholders from China's pharmaceutical industry to jointly explore pathways to high-quality development and build a value-centered platform for innovation matchmaking and industry ecosystem connection.
Livestream Preview | Enabling the Last Mile for Blockbuster New Drugs with AIGlobal expansion has become a key priority in today's healthcare industry. Innovative pharmaceutical companies need to formulate science-based global development strategies that fully account for the characteristics of the drug itself, as well as the medical needs and regulatory environments of different markets, in order to stand out in global competition. At the same time, AI is accelerating the reshaping of drug R&D paradigms and becoming an important driver of clinical research, supporting the full workflow from protocol design to data analysis and accelerating the globalization of innovative drugs.
EClinCloud Partners with Yuanzi Technology's eHuiQian to Further Advance Clinical Research ComplianceIn October 2025, EClinCloud partnered with Yuanzi Technology on the compliant electronic signature system eHuiQian. Together, both parties will leverage an intelligent, interconnected technology framework to provide digital compliance support for global clinical research projects.
EClinCloud Invited to Join the AI+ Biopharmaceutical Ecosystem Alliance to Build an Intelligent Innovation Ecosystem TogetherOn October 28, the Harbour BioMed Global R&D Day ("Illuminating Harbour with Intelligence, Gathering Stars of Innovation") was successfully held in Shanghai, China. At the event, the AI+ Biopharmaceutical Ecosystem Alliance was officially launched. EClinCloud was invited to attend as an alliance member; the company's Co-founder and Chief Business Officer Su Quanyu attended in person and joined industry peers to witness the inauguration of the alliance.
Media Coverage | EClinCloud: What Enables Clinical Research to "Outrun Time"..."Developing a new drug from R&D to market launch takes an average of 10 to 15 years and billions of dollars in investment, while drugs entering clinical trials have less than a 10% probability of ultimate approval." In EClinCloud's Ningbo office, Qin Long spoke with a note of reflection about these "harsh figures" of the pharmaceutical industry.
EClinCloud at DIA Japan 2025 | Joining Global Partners to Discuss Clinical Research InnovationFrom October 19 to 21, the 22nd DIA Japan Annual Meeting was successfully held at Tokyo Big Sight. The theme of this annual meeting was: "A Strong Bond Connecting Japan, Asia, and the World—Co-creating a 'Future New Normal' to Benefit Patients."
"Versatile" eCOA: Supporting Global Clinical TrialsAbout EClinCloud: EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it develops an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products such as eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, alongside scale management, linguistic validation, rater training, and data quality analysis services to build efficient, accurate digital solutions. Relying on AI predictive models and an intelligent data platform, it dynamically assesses and assists in improving drug clinical trial success rates, helping shorten drug and device R&D cycles to benefit patients.
Family and National Reunion: EClinCloud Celebrates the Dual Holidays with You!About EClinCloud: EClinCloud is a leading AI company in the clinical research industry. Powered by AI, it develops an integrated clinical intelligence cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient, precise digital solutions. Leveraging AI predictive models and an intelligent data platform, EClinCloud dynamically evaluates and helps improve the success rate of drug clinical trials, helping shorten drug and medical device development cycles to benefit patients.